GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...

SandboxAQ today announced it has expanded its relationship with Deloitte to offer SandboxAQ's AI LQM simulation products and solutions along with Deloitte's services capabilities to organizations ...

In the past few years, there has been extensive usage of knowledge graphs (KG) that connect concepts ... is a senior consultant at MP Advisors, a biopharma-only strategy and financial advisory ...

Tools like knowledge graphs have been pivotal in uncovering ... She advises clients on a wide range of assignments in the sector (from biopharma to pharma service providers), including the ...

representing a compelling opportunity for Accord BioPharma to broaden patient access to biologics and build scale in immunology, a high-demand therapeutic area. "Our U.S. portfolio of biosimilars ...

Year-over-year BioSpace data shows there were fewer job postings live on the website in the fourth quarter of 2024, and the ...

PowerUp Acquisition Corp. (NASDAQ:PWUP), a special purpose acquisition company currently valued at $88.29 million, has announced the successful approval of its merger with Aspire Biopharma ...

RALEIGH, N.C., Feb. 10, 2025 /PRNewswire/ -- Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd. ("Intas Pharmaceuticals"), focused on ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Quantum BioPharma Ltd. has announced the retention of Enterprise Canada Inc. and Empire Market Ventures, LLC to enhance its public relations and investor awareness programs in key markets.

PowerUp Acquisition Corp. (NASDAQ:PWUP), a special purpose acquisition company currently valued at $88.29 million, has announced the successful approval of its merger with Aspire Biopharma, Inc., a ...